Dana-Farber Research Advances Lead to FDA Label Update for Primary CNS Lymphoma
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
In a groundbreaking advancement that promises to revolutionize the field of immunotherapy, researchers have unveiled a pioneering two-stage inertial microfluidics ...
In the rapidly evolving landscape of immunotherapy, a groundbreaking approach is emerging that holds transformative potential for pediatric autoimmune diseases. ...
In a significant leap forward for cancer immunotherapy, researchers at MIT and Harvard Medical School have unveiled an innovative method ...
Four trailblazing scientists—Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain—have been jointly honored with the 2025 Richard N. Merkin ...
In the evolving landscape of cancer treatment, particularly concerning hematological malignancies such as multiple myeloma and lymphoma, Car-T cell therapy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine